Ovid Therapeutics Inc. - Demonstração de Resultados (TTM)

Ovid Therapeutics Inc.
US ˙ NasdaqCM ˙ US6904691010

Demonstração de Resultados (TTM)

A Demonstração de Resultados de Ovid Therapeutics Inc. mostra mudanças na receita e despesas ao longo de um período de tempo. Os dados da Demonstração de Resultados incluem Vendas e Receita, Lucro Bruto, Pesquisa e Desenvolvimento (P&D), Despesas de Vendas, Gerais e Administrativas (SG&A), Renda Operacional, Despesa com Imposto de Renda, Despesa com Juros, Renda Não Operacional, Lucro por Ação (EPS) e Ações em Circulação.

Todos os números são vezes 1,000,000 exceto unidades por ação.

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
Receita 221 214 208 1 1 1 2 0 0 0 0 0 1 1 1 1 7 7 7 7
Mudar (%) -3.13 -2.66 -99.31 0.00 0.77 3.18 -91.79 60.79 49.35 32.31 20.92 19.83 11.27 -10.44 -3.18 1,113.69 -0.62 9.71 -1.79
% da receita 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Custo das vendas
Mudar (%)
% da receita
Lucro Operacional Bruto 221 214 208 1 1 1 2 0 0 0 0 0 1 1 1 1 7 7 7 7
Mudar (%) -3.13 -2.66 -99.31 0.00 0.77 3.18 -91.79 60.79 49.35 32.31 20.92 19.83 11.27 -10.44 -3.18 1,113.69 -0.62 9.71 -1.79
% da receita 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Vendas, Gerais e Administrativas 40 39 37 32 32 33 32 31 32 31 30 28 26 27 24 22 21 20 24 25
Mudar (%) -1.69 -5.45 -15.30 2.94 2.67 -2.70 -4.74 2.23 -2.62 -3.82 -3.97 -7.56 2.81 -11.53 -7.31 -5.51 -3.62 19.58 5.16
% da receita 18.13 18.39 17.87 2,181.99 2,246.23 2,288.66 2,158.21 25,041.18 15,922.16 10,382.06 7,547.19 5,993.46 4,623.24 4,271.68 4,219.79 4,039.60 314.51 305.01 332.45 355.98
P&D 57 46 47 39 36 37 25 23 25 24 28 32 37 40 35 31 27 25 26 30
Mudar (%) -19.33 2.64 -17.93 -7.62 4.40 -33.74 -4.94 5.35 -4.67 20.79 13.32 15.20 6.82 -11.42 -10.66 -14.11 -7.40 2.67 17.68
% da receita 25.65 21.36 22.53 2,665.27 2,462.07 2,550.82 1,638.23 18,966.41 12,426.76 7,932.43 7,241.84 6,786.92 6,524.47 6,263.61 6,195.58 5,716.97 404.56 376.96 352.76 422.69
OpEx 97 85 84 70 68 70 57 54 56 54 58 61 63 67 59 53 48 45 50 55
Mudar (%) -12.03 -1.11 -16.77 -2.87 3.58 -19.06 -4.83 3.58 -3.52 6.84 4.50 4.52 5.15 -11.46 -9.30 -10.55 -5.74 10.23 11.60
% da receita 43.78 39.76 40.39 4,847.26 4,708.30 4,839.47 3,796.44 44,007.59 28,348.92 18,314.50 14,789.03 12,780.38 11,147.71 10,535.28 10,415.37 9,756.57 719.06 681.97 685.20 778.67
Lucro operacional 124 129 124 -69 -67 -69 -56 -54 -56 -54 -58 -60 -63 -66 -58 -53 -41 -38 -42 -48
Mudar (%) 3.80 -3.69 -155.24 -2.93 3.64 -19.53 -2.47 3.45 -3.70 6.70 4.38 4.40 5.10 -11.47 -9.36 -22.19 -6.57 10.32 13.89
% da receita 56.22 60.24 59.61 -4,747.26 -4,608.30 -4,739.47 -3,696.44 -43,907.59 -28,248.92 -18,214.50 -14,689.03 -12,680.38 -11,047.71 -10,435.28 -10,315.37 -9,656.57 -619.06 -581.97 -585.20 -678.67
Despesa com juros -0 -0
Mudar (%) -4.60
% da receita -0.21 -0.20
Resultado líquido 122 127 123 -69 -68 -69 -54 -51 -49 -49 -52 -51 -30 -33 -26 -25 -38 -36 -17 -24
Mudar (%) 4.14 -3.13 -156.40 -1.73 0.86 -21.11 -5.08 -4.24 -1.45 7.87 -3.18 -41.30 9.26 -18.67 -5.52 52.87 -4.84 -52.07 38.78
% da receita 55.10 59.23 58.95 -4,793.30 -4,710.28 -4,714.44 -3,604.66 -41,672.99 -24,819.57 -16,377.00 -13,351.79 -10,691.35 -5,237.32 -5,142.72 -4,670.14 -4,557.30 -574.02 -549.62 -240.13 -339.33

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:1OT € 2,02
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista